Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial

  1. Rini, B.I.
  2. Escudier, B.
  3. Tomczak, P.
  4. Kaprin, A.
  5. Szczylik, C.
  6. Hutson, T.E.
  7. Michaelson, M.D.
  8. Gorbunova, V.A.
  9. Gore, M.E.
  10. Rusakov, I.G.
  11. Negrier, S.
  12. Ou, Y.-C.
  13. Castellano, D.
  14. Lim, H.Y.
  15. Uemura, H.
  16. Tarazi, J.
  17. Cella, D.
  18. Chen, C.
  19. Rosbrook, B.
  20. Kim, S.
  21. Motzer, R.J.
Aldizkaria:
The Lancet

ISSN: 1474-547X 0140-6736

Argitalpen urtea: 2011

Alea: 378

Zenbakia: 9807

Orrialdeak: 1931-1939

Mota: Artikulua

DOI: 10.1016/S0140-6736(11)61613-9 GOOGLE SCHOLAR